Diabetes reduces left ventricular ejection fraction-irrespective of presence and extent of coronary artery disease

European Journal of Endocrinology

Volumn 165, Issue 6, 2011, Pages 945-951

  Ehl, Niklas F ^a   Kuḧne, Michael ^a   Brinkert, Miriam ^a   Mul̈ler Brand, Jan ^a   Zellweger, Michael J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUMMED DIFFERENCE SCORE; SUMMED REST SCORE; SUMMED STRESS SCORE;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 81555195442     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0687     Document Type: Article

References (39)

1. MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, Aguilar D, Krum H & McMurray JJ. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal 2008 29 1224-1240. (doi:10.1093/ eurheartj/ehn156)
2. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS & Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. European Heart Journal 2006 27 65-75. (doi:10.1093/eurheartj/ehi555)
3. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali JK & Wilson AC. Diabetes mellitus, a predictor of morbidityandmortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. American Journal of Cardiology 1996 77 1017-1020. (doi:10.1016/S0002-9149(97)89163-1)
4. Nichols GA, Gullion CM, Koro CE, Ephross SA & Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 2004 27 1879-1884. (doi:10.2337/diacare.27.8. 1879)
5. Kannel WB, Hjortland M & Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. American Journal of Cardiology 1974 34 29-34. (doi:10.1016/0002-9149(74)90089-7)
6. McKee PA, Castelli WP, McNamara PM & Kannel WB. The natural history of congestive heart failure: the Framingham study. New England Journal of Medicine 1971 285 1441-1446. (doi:10.1056/ NEJM197112232852601)
7. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr & Sowers JR. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999 100 1134-1146. (doi:10.1161/01.CIR.100.10.1134)
8. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T, Braunwald E, Jaffe AS & MILIS study group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. Journal of the American College of Cardiology. 1989 14 49-57. (doi:10.1016/0735-1097(89)90053-3)
9. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C & Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Archives of InternalMedicine 2001 161 996-1002. (doi:10.1001/archinte.161.7.996)
10. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW & Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. American Journal of Cardiology 1972 30 595-602. (doi:10.1016/0002-9149(72)90595- 4)
11. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, Friedman JD, Zellweger MJ & Berman DS. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999 100 1035-1042. (doi:10.1161/01.CIR.100.10.1035)
12. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, Maddahi J & Germano G. Separate acquisition rest thallium- 201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. Journal of the American College of Cardiology 1993 22 1455-1464. (doi:10.1016/0735-1097(93)90557-H)
13. Zellweger MJ, Kaiser C, Brunner-La Rocca HP, Buser PT, Osswald S, Weiss P, Mueller-Brand J & Pfisterer ME. Value and limitations of target-vessel ischemia in predicting late clinical events after drugeluting stent implantation. Journal of Nuclear Medicine 2008 49 550-556. (doi:10.2967/jnumed. 107.046771)
14. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO & Smith SC Jr. ACC/AHA guideline update for exercise testing: summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002 106 1883-1892. (doi:10.1161/01.CIR. 0000034670.06526.15)
15. Zellweger MJ, Tabacek G, Zutter AW, Weinbacher M, Cron TA, Muller-Brand J & Pfisterer ME. Evidence for left ventricular remodeling after percutaneous coronary intervention: effect of percutaneous coronary intervention on left ventricular ejection fraction and volumes. International Journal of Cardiology 2004 96 197-201. (doi:10.1016/j.ijcard.2003.06.016)
16. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, Germano G, Van Train K & Diamond GA. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. Journal of the American College of Cardiology 1995 26 639-647. (doi:10.1016/0735-1097(95)00218-S)
17. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J & Diamond GA. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996 93 905-914. (doi:10.1161/01.CIR.93.5.905)
18. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF & Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. Journal of Nuclear Medicine 1995 36 2138-2147.
19. Sciagra R, Berti V, Genovese S & Pupi A. Reliability of myocardial perfusion gated SPECT for the reproducible evaluation of resting left ventricular functional parameters in long-term follow-up. European Journal of Nuclear Medicine and Molecular Imaging 2010 37 1722-1729. (doi:10.1007/s00259- 010-1444-y)
20. Hovland A, Staub UH, Bjornstad H, Prytz J, Sexton J, Stoylen A & Vik-Mo H. Gated SPECT offers improved interobserver agreement compared with echocardiography. Clinical Nuclear Medicine 2010 35 927-930. (doi:10.1097/RLU.0b013e3181f9ddfb)
21. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO Jr, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ & Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Journal of the American College of Cardiology 2003 42 1318-1333. (doi:10.1016/j.jacc.2003.08.011)
22. Chareonthaitawee P, Sorajja P, Rajagopalan N, Miller TD, Hodge DO, Frye RL & Gibbons RJ. Prevalence and prognosis of left ventricular systolic dysfunction in asymptomatic diabetic patients without known coronary artery disease referred for stress single-photon emission computed tomography and assessment of left ventricular function. American Heart Journal 2007 154 567-574. (doi:10.1016/j.ahj.2007.04.042)
23. Htay T, Mehta D, Heo J & Iskandrian AE. Left ventricular function in patients with type 2 diabetes mellitus. American Journal of Cardiology 2005 95 798-801. (doi:10.1016/j.amjcard.2004.11. 043)
24. Konduracka E, Gackowski A, Rostoff P, Galicka-Latala D, Frasik W & Piwowarska W. Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy. European Heart Journal 2007 28 2465-2471. (doi:10.1093/eurheartj/ehm361)
25. Mustonen JN, Uusitupa MI, Laakso M, Vanninen E, Lansimies E, Kuikka JT & Pyorala K. Left ventricular systolic function in middleaged patients with diabetes mellitus. American Journal of Cardiology 1994 73 1202-1208. (doi:10.1016/0002-9149(94)90182-1)
26. Henry RM, Paulus WJ, Kamp O, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM & Stehouwer CD. Deteriorating glucose tolerance status is associated with left ventricular dysfunction - the Hoorn Study. Netherlands Journal of Medicine 2008 66 110-117. (Pubitemid 351447487)
27. Loimaala A, Groundstroem K, Majahalme S, Nenonen A & Vuori I. Impaired myocardial function in newly onset type 2 diabetes associates with arterial stiffness. European Journal of Echocardiography 2006 7 341-347. (doi:10.1016/j.euje.2005.07.001)
28. Ammann P, Brunner-La Rocca H, Fehr T, Munzer T, Sagmeister M, Angehrn W & Rickli H. Coronary anatomy and left ventricular ejection fraction in patients with type 2 diabetes admitted for elective coronary angiography. Catheterization and Cardiovascular Interventions 2004 62 432-438. (doi:10.1002/ccd.20135)
29. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ & Dargie HJ. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997 350 829-833. (doi:10.1016/S0140-6736(97)03033-X)
30. Silva JA, Escobar A, Collins TJ, Ramee SR & White CJ. Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients. Circulation 1995 92 1731-1736. (doi:10.1161/01.CIR.92.7.1731)
31. Ingelsson E, Sundstrom J, Arnlov J, Zethelius B & Lind L. Insulin resistance and risk of congestive heart failure. Journal of the American Medical Association 2005 294 334-341. (doi:10.1001/ jama.294.3.334)
32. Smooke S, Horwich TB & Fonarow GC. Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. American Heart Journal 2005 149 168-174. (doi:10.1016/j.ahj.2004.07. 005)
33. Witteles RM & Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. Journal of the American College of Cardiology 2008 51 93-102. (doi:10.1016/ j.jacc.2007.10.021)
34. Hildebrandt P, Wachtell K, Dahlof B, Papademitriou V, Gerdts E, Giles T, Oikarinen L, Tuxen C, Olsen MH & Devereux RB. Impairment of cardiac function in hypertensive patients with type 2 diabetes: a LIFE study. Diabetic Medicine 2005 22 1005-1011. (doi:10.1111/j.1464-5491.2005.01564.x)
35. Chung AK, Das SR, Leonard D, Peshock RM, Kazi F, Abdullah SM, Canham RM, Levine BD & Drazner MH. Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: The Dallas Heart Study. Circulation 2006 113 1597-1604. (doi:10.1161/CIRCULATIONAHA. 105. 574400)
36. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD, Hayes SW, Cohen I, Germano G & Berman DS. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. European Heart Journal 2011 32 1012-1024. (doi:10.1093/ eurheartj/ehq500)
37. Zhang L, Zhang S, Jiang H, Sun A, Zou Y & Ge J. Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized controlled trials. Clinical Cardiology 2011 34 117-123. (doi:10.1002/clc.20821)
38. Andersson C,Weeke P, Pecini R, Kjaergaard J, Hassager C, Kober L & Torp-Pedersen C. Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure. Scandinavian Cardiovascular Journal 2010 44 37-44. (doi:10. 3109/14017430903312438)
39. De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E & Bauters C. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. European Heart Journal 2004 25 656-662. (doi:10.1016/j.ehj.2004.01.010)